Are insulin-treated type 2 diabetic subjects at higher risk for foot ulcers? [8]

Diabetes Care

Volumn 22, Issue 8, 1999, Pages 1379-1380

  Ezio, Faglia ^a,d   Fabrizio, Favales ^b   Antonella, Quarantiello ^a   Patrizia, Calia ^b   Alberto, Morabito ^c  

^a IRCCS MULTIMEDICA   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d Policlinico Multimedia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; ANKLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOOT ULCER; HIGH RISK POPULATION; HUMAN; HYPERTENSION; LETTER; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; TIBIA;

DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0032776826     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.8.1379     Document Type: Letter

References (12)

1. Klenerman L, McCabe C, Cogley D, Crerand S, Laing P, White M: Screening for patients at risk of diabetic foot ulceration in a general diabetic outpatient clinic. Diabet Med 13:561-563, 1996
2. McNeely MJ, Boyko EJ, Arhoni JH, Stensel VL, Reiber GE, Smith DG, Pecoraro RE: The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration: how great are the risks? Diabetes Care 18:216-219, 1995
3. Siitonen OI, Niskanen LK, Laakso M, Siitonen JT, Pyörälä K: Lower-extremity amputations in diabetic and nondiabetic patients: a population-based study in eastern Finland. Diabetes Care 16:16-20, 1993
4. Rosenblum BI, Pomposelli FB Jr, Giurini JM, Gibbons GW, Freeman DV, Chrzan JS, Campbell DR, Habershaw GM, LoGerfo FW: Maximizing foot salvage by a combined approach to foot ischemia and neuropathic ulceration in patients with diabetes: a 5-year experience. Diabetes Care 17:983-987, 1994
5. Bresater LE, Welin L, Romanus B: Foot pathology and risk factors for diabetic foot disease in elderly men. Diabetes Res Clin Pract 32:103-109, 1996
6. Lehto S, Rönnemaa T, Pyörälä K, Laakso M: Risk factors predicting lower extremity amputations in patients with NIDDM. Diabetes Care 19:607-612, 1996
7. El-Shazly M, Abdel-Fattah M, Scorpiglione N, Massi Benedetti M, Capani F, Carinci F, Carta Q, Cavaliere D, De Feo E, Taboga C, Tognoni G, Nicolucci A, on behalf of the Italian Study Group for the implementation of the St. Vincent Declaration: Risk factors for lower limb complications in diabetic patients J Diabetes Complications 12:10-17, 1998
8. Segalini G, Aldeghi A, Morabito A, Radice M, for the Lombardy Diabetic Foot Study: A multi-centre study on the prevalence of lower extremity ulcers and amputations among diabetic out-patients in the Lombardy region. Diabetes Nutr Metab 11:179-187, 1998
9. Genuth S: Insulin use in NIDDM. Diabetes Care 13:1240-1264, 1990
10. Rifkin H (Ed.): The Physician Guide to Type 2 Diabetes (NIDDM): Diagnosis and Treatment. Alexandria, VA, American Diabetes Association, 1985
11. Pecoraro RE, Reiber GE, Burgess EM: Pathways to diabetic limb amputation: basis for prevention. Diabetes Care 13:513-521, 1990
12. Apelqvist J, Castenfors J, Larsson J, Stenström A, Agardh C-D: Prognostic value of systolic ankle and toe blood pressure levels in outcome of diabetic foot ulcer. Diabetes Care 12:373-378, 1989